$6.71 0.01 (+0.15%)
11/27/2009 11:38 AM

PDL BioPharma, Inc. (PDLI)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.

Featured Broker Partners